Stephen M Prescott, Raymond L White  Cell 

Slides:



Advertisements
Similar presentations
Ivan P. Gorlov, Olga Y. Gorlova & Christopher I. Amos.
Advertisements

Bonny Blackard Biology 169 April 4, 2006
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Oncogene at last—c-Jun promotes liver cancer in mice
Does Reduced Creatine Synthesis Protect against Statin Myopathy?
Protein secretion: Getting folded proteins across membranes
IL-22 Gets to the Stem of Colorectal Cancer
Connecting COX-2 and Wnt in cancer
Genetics of Cancer.
Apoptosis: Does stress kill?
The promise of cancer genetics
Accelerating drug discovery: Open source cancer cell biology?
HSF1 in Translation Cancer Cell
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
The Lingering Enigma of the Allelic Exclusion Mechanism
Stopping the Clock with MYC
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Volume 29, Issue 5, Pages (November 2008)
New class of anti-inflammatory agents for colonic epithelial cells
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Whipping NF-κB to Submission via GADD45 and MKK7
Cell signaling and cancer
Getting to the heart of COX-2 inhibition
Autophagy: Paying Charon's Toll
Epithelial-Mesenchymal Transitions
Making Sense of HDAC2 Mutations in Colon Cancer
The Wind God Promotes Lung Cancer
Volume 13, Issue 1, Pages 1-2 (January 2008)
Methed-Up FOXOs Can't In-Akt-ivate
The promise of cancer genetics
Getting to the heart of COX-2 inhibition
The Autistic Neuron: Troubled Translation?
Taking the Study of Cancer Cell Survival to a New Dimension
Plant hormones: Dissecting the gibberellin response pathway
Soledad Matus, Danilo B. Medinas, Claudio Hetz  Cell Stem Cell 
BMP Receptor 1a and Juvenile Polyposis Syndrome
Wnt Signaling: It Gets More Humorous with Age
Volume 6, Issue 3, Pages (September 2004)
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Dongwon Kim, Luis A. Garza  Journal of Investigative Dermatology 
Volume 3, Issue 4, Pages (April 2003)
Volume 130, Issue 2, Pages (February 2006)
Volume 119, Issue 3, Pages (September 2000)
The Epigenomics of Cancer
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Stop that Noise and Turn Up the Antisense Transcription
Roger Schneiter, Sepp D Kohlwein  Cell 
Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma  Sean Whittaker  Journal of.
Small Molecules, Big Effects: A Role for Chromatin-Localized Metabolite Biosynthesis in Gene Regulation  Bryan A. Gibson, W. Lee Kraus  Molecular Cell 
Phytochromes: Where to Start?
Current Compensation in Neuronal Homeostasis
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Nuclear Decay Factors Crack Up mRNA
Division of Labor: Minor Splicing in the Cytoplasm
A Versatile Transcriptional Effector of Wingless Signaling
Muhammad Shoaib, Claus Storgaard Sørensen  Cancer Cell 
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Progress in Cutaneous Cancer Research1
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Hijacking the Cell: Parasites in the Driver's Seat
Apoptosis: Current Biology
A common pathway for genetic events leading to pheochromocytoma
Mutations and aneuploidy
Volume 22, Issue 4, Pages (April 2018)
Volume 4, Issue 4, Pages (April 2009)
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Tenets of PTEN Tumor Suppression
Skp2, the FoxO1 hunter Cancer Cell
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2  Stephen M Prescott, Raymond L White  Cell  Volume 87, Issue 5, Pages 783-786 (November 1996) DOI: 10.1016/S0092-8674(00)81983-2

Figure 1 Prostaglandin Synthase-2 (COX-2) Is an Early, Causal Event in the APC Pathway to Colon Polyps and Cancer Recent evidence (includingOshima et al. 1996) places COX-2 after the loss of the second allele of APC and the morphological appearance of a very early polyp (<2 mm). Mice that are genetically altered to be COX-2 deficient, or that receive a selective inhibitor of COX-2, are strongly protected against the development of colon polyps even with a germline mutation in APC. The steps between functional loss of both APC alleles and increased expression of COX-2 are unknown but likely involve increased transcription of this normally silent gene. Once expressed, the majority of COX-2 is strategically located in the nuclear membrane (DeWitt and Smith 1995). The mechanism(s) by which increased prostaglandin synthesis promote tumorigenesis also is unknown but there are several promising clues. One intriguing finding is that expression of COX-2 impairs the apoptotic response (Tsujii and DuBois 1995). Cell 1996 87, 783-786DOI: (10.1016/S0092-8674(00)81983-2)

Figure 2 Reactions Catalyzed by Prostaglandin Synthase See text for details. Cell 1996 87, 783-786DOI: (10.1016/S0092-8674(00)81983-2)

Figure 3 Mechanisms by Which Prostaglandins Regulate Cellular Events See text for details. Cell 1996 87, 783-786DOI: (10.1016/S0092-8674(00)81983-2)